Real-world effectiveness of COVID-19 vaccine in people with HIV compared with a matched HIV-negative cohort: A test-negative design
A complete primary series of COVID-19 vaccines offered significant protection against SARS-CoV-2 infection and severe outcomes in both PWH and PWoH populations, although this wanes with time. However, the estimate of VE against SARS-CoV-2 infection appeared lower in PWH than in PWoH and the degree of waning over time was relatively quicker in PWH.
Authors
- Sharon Weissman (ORCID: https://orcid.org/0000-0002-2854-5745)
- Xueying Yang (ORCID: https://orcid.org/0000-0001-6788-0688)
- Ziang Liu (ORCID: https://orcid.org/0000-0002-1364-3502)
- Nancy Phaswana‐Mafuya (ORCID: https://orcid.org/0000-0001-9387-0432)
- Gregory A. Poland (ORCID: https://orcid.org/0000-0001-5057-4457)
- Bankole Olatosi (ORCID: https://orcid.org/0000-0002-8295-8735)
- Jiajia Zhang (ORCID: https://orcid.org/0009-0007-6884-0638)
- Xiaoming Li (ORCID: https://orcid.org/0000-0002-5555-9034)
- Shujie Chen (ORCID: https://orcid.org/0000-0001-5319-4660)
Institutions
- South African Medical Research Council (ZA)
- Mayo Clinic (US)
- University of South Carolina (US)
- University of Johannesburg (ZA)
- Department of Health Services (US)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2024-11-23
- DOI
- https://doi.org/10.1016/j.ijid.2024.107310
- Citations
- 3
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 1.17
Funders
- Foundation for the National Institutes of Health
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases